Zurueck zur Suche

Reporte zur Charge GJ2524 GIANT 34

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

2Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MD 2

VAERS 2499738

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ2524 GIANT 34

gering
Staat
MD
Alter
41,0
Geschlecht
F
Eingang
05.11.2022
Impfdatum
06.03.2021
Beginn
22.10.2021
Tage bis Beginn
230,0
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 COVID-19 immunisation

Symptomtext

SUSPECTED COVID-19 INFECTION (HEADACHE, COLD LIKE SYMPTOMS); REVACCINATION WITH DIFFERENT COVID-19 VACCINE; This spontaneous report received from a patient via Pfizer concerned a 43 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: drug allergy. The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin not reported, batch number: 1805022 expiry: UNKNOWN) dose was not reported, 01 total, administered on left arm on 06-MAR-2021 09:00 for covid-19 prophylaxis. Age at time of vaccination 41 years old. Concomitant medications included Advil (ibuprofen) for drug used for unknown indication It was unknown whether patient had any adverse events following vaccination with covid-19 vaccine ad26.cov2.s (Dose number in series 1). The patient received additional dose of non-company suspect vaccine Moderna COVID-19 vaccine (elasomeran) (Dose number in series 2) (form of administration and route of administration were not reported, batch number: 012F21A CVS#1517 expiry: UNKNOWN) dose was not reported, administered on left arm on 22-OCT-2021 for covid-19 prophylaxis. On 22-OCT-2021, the patient revaccinated with different covid-19 vaccine (Dose number in series 2). The patient received additional dose of non-company suspect vaccine Pfizer (tozinameran) (Dose number in series 3) (form of admin and route of admin were not reported, batch number: GJ2524 GIANT 348 expiry: UNKNOWN) dose was not reported, administered on left arm on 15-SEP-2022 12:00 for covid-19 prophylaxis. On OCT-2022, the patient experienced suspected covid-19 infection and she received covid-19 treatment of unspecified drug (form of administration and route of administration were not reported, batch number: unknown and expiry: unknown) dose was not reported, administered from 07-OCT-2022 till 11-OCT-2022 for covid-19 treatment. 7 days after covid-19 treatment on 18-OCT-2022, symptoms again started with headache and cold like symptoms (Dose number in series 3). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from suspected covid-19 infection (headache, cold like symptoms), and the outcome of revaccination with different covid-19 vaccine was not reported. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Drug allergy
Vorgeschichte
-
Andere Medikamente
ADVIL [IBUPROFEN]
Allergien
-
Vorherige Impfungen
-

VAERS 2489545

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge GJ2524 Giant 34

gering
Staat
MD
Alter
43,0
Geschlecht
F
Eingang
26.10.2022
Impfdatum
15.09.2022
Beginn
15.09.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Drug ineffective Interchange of vaccine products SARS-CoV-2 test

Symptomtext

Treatment of COVID-19; Treatment of COVID-19; Interchange of vaccine products; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient. A 43-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 15Sep2022 at 12:00 as dose 3 (booster), single (Lot number: GJ2524 Giant 348) at the age of 43 years, in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 22Oct2021 as dose 2 (booster), single (Lot number: 012F21A CVS#1517), in left arm for covid-19 immunisation; coviD-19 vaccine nrvv ad26 (jnj 78436735) (COVID-19 VACCINE JANSSEN), on 06Mar2021 at 09:00 as dose 1, single (Lot number: 1805022), in left arm for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: ADVIL 12 HORAS, start date: 04Oct2022, stop date: 11Oct2022. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 15Sep2022 at 12:00, outcome "unknown"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment, Therapeutic measures were taken as a result of drug ineffective, covid-19. Additional information: The patient had no known allergies. Anti-viral details: Paxlovid Product=COVID 19 Treatment, Treatment start date=07Oct2022, Treatment stop date=11Oct2022, Indication=Treatment of COVID-19.

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
Test Name: COVID-19 test; Test Result: Positive ; Comments: COVID 19 Treatment,
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: No adverse event
Andere Medikamente
ADVIL 12 HORAS
Allergien
-
Vorherige Impfungen
-